Safety Clinical Trials

25 recruiting

Safety Trials at a Glance

111 actively recruiting trials for safety are listed on ClinicalTrialsFinder across 6 cities in 45 countries. The largest study group is Not Applicable with 28 trials, with the heaviest enrollment activity in Shanghai, Beijing, and Hangzhou. Lead sponsors running safety studies include Regional Cardiology Center, The Copper Health Centre (MCZ),, Changchun GeneScience Pharmaceutical Co., Ltd., and Affiliated Hospital of Nantong University.

Treatments under study

About Safety Clinical Trials

Looking for clinical trials for Safety? There are currently 25 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Safety trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Safety clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 111 trials

Recruiting
Phase 1

A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.

Focus of the Study: Safety of XFB19
Xfibra, Inc.40 enrolled1 locationNCT05361733
Recruiting
Not Applicable

Digital Microlearning and Patient Safety in Nursing Students

Patient SafetyMedical Education
Agri Ibrahim Cecen University100 enrolled1 locationNCT07367906
Recruiting

Efficacy of Thermal Ablation Combined With Antithyroid Drugs in the Treatment of Primary Hyperthyroidism

Efficacy and SafetyHyperthyroidism/ThyrotoxicosisComplication Rate+1 more
Chinese PLA General Hospital454 enrolled1 locationNCT07557810
Recruiting
Not Applicable

The Effectiveness of Gamified Metaverse-Based Training on Patient Safety for Nursing Students

Patient SafetyNursing EducationGamification+1 more
Baskent University60 enrolled1 locationNCT07394907
Recruiting
Phase 3

A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group

Long Term Efficacy and Safety
Hansa Biopharma AB150 enrolled14 locationsNCT05937750
Recruiting

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Allergic Bronchopulmonary AspergillosisEfficacy and SafetyABPA+3 more
Qianfoshan Hospital50 enrolled1 locationNCT07362693
Recruiting
Not Applicable

Operating Room Black Box Supported Debriefings and Their Effect on Healthcare Professionals Effectiveness and Psychological Safety.

StressResiliencePsychological Safety+2 more
ORNND - Operating Room Nurse Network Denmark135 enrolled3 locationsNCT07396675
Recruiting
Phase 1

A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)

SafetyTolerabilityAdult Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd.64 enrolled1 locationNCT07016802
Recruiting
Not Applicable

Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

Health DisparitiesPatient SafetyQuality Improvement+3 more
Boston Children's Hospital656 enrolled1 locationNCT05407129
Recruiting

Community Safety and Violence

Community-Centered Safety
NYU Langone Health15 enrolled1 locationNCT07494019
Recruiting
Phase 4

Safety of PET MPI Using the CRCHUM N-13 Ammonia

N-13 Ammonia Safety
Centre hospitalier de l'Université de Montréal (CHUM)20,000 enrolled1 locationNCT03275584
Recruiting
Not Applicable

Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger

Efficacy and SafetyRandomised Clinical TrialTrigger Finger+3 more
Konya Beyhekim Training and Research Hospital60 enrolled1 locationNCT07256522
Recruiting
Phase 1

Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer

SafetyDemoralization
Gustavo Vazquez15 enrolled1 locationNCT06818994
Recruiting

Post-marketing Clinical Monitoring of Safety and Performance of Breast Tissue Expander for Breast Reconstruction

Safety and PerformanceBreast Tissue Expander
Silimed Industria de Implantes Ltda152 enrolled3 locationsNCT06981481
Recruiting

An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants With Smooth Surface

Quality of LifeBreast Implant; ComplicationsSatisfaction+1 more
Silimed Industria de Implantes Ltda384 enrolled1 locationNCT05345821
Recruiting

A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

SafetyPneumococcal Immunization
Pfizer660 enrolled1 locationNCT06760208
Recruiting
Phase 1

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

First in Man Study to Evaluate Initial Safety
Gliknik Inc.70 enrolled1 locationNCT05318534
Recruiting
Phase 1Phase 2

Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

SafetyPARKINSON DISEASE (Disorder)Apathy
Integrative Research Laboratories AB75 enrolled13 locationsNCT07461220
Recruiting
Early Phase 1

Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis

EfficacyTreatmentChronic Kidney Diseases+3 more
The First Affiliated Hospital with Nanjing Medical University9 enrolled1 locationNCT04592640
Recruiting

Smartphone Use in Healthcare Settings Among Nurses

Clinical CommunicationPatient SafetyNursing Care+2 more
Alexandria University384 enrolled1 locationNCT07449533